Anavex Life Sciences Corp (AVXL)

[Amatuer17]

The people in the market who matter do not consider A2-73 worthy of mentioning in key reports - that shows that the results are not convincing. Market is so much thirsty for any effective AD treatment that even 20-25% effective product would lead to high market hype and SP jumping - nothing has happened despite repeatedly presenting those results many times. The KOL s just ignore those results

Every biotech is for sale - even a co like CELG is sold - so one statement is true for every biotech/pharma is - they are up for sale. They may say different things but when they see money on table, they just sale. As market is not convinced about their A2-73 they probably did not get high enough offer.